| Title |
|
|
|
Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Molecular Oncology | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
1574-7891
1878-0261
| |
| Volume/pages |
|
|
|
12:6(2018), p. 830-854
| |
| ISI |
|
|
|
000434152600005
| |
| Pubmed ID |
|
|
|
29603584
| |
| Full text (Publisher's DOI) |
|
|
| | |
|